We know the potential of this drug.We know its multi acting,...

We know the potential of this drug.

We know its multi acting, consistent (oh so consistent) and safe!

We add on DMOAD connotations, more to come tomorrow *fingers crossed*.

We know just how many inflammatory conditions there are and how many of those we may at least partially address in a good % of the population.

We, in my opinion must not sell this short...we want a Big Pharma partnership, NOT a buy out...a buyout at anything under x would be the saddest loss for us. A total wipe out of all that potential. I think there are enough smart and longer term holders that can stave this off but we would need every share we could muster. I want to see the day when x is much more than just $50 or $100 and we are reaping in half yearly dividends that are material.

I want to see the day when WE as owners also help society directly, the poorest and most suffering on a scale that matters while also being a compelling investment for us that have held for so long and so dearly.